Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions GlobeNewswire November 03, 2025 – Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 participants in total by early 2026, […]

Eagle Bancorp, Inc. Announces Leadership Transition GlobeNewswire November 03, 2025 Chair, President and CEO Susan G. Riel to Retire in 2026 Board Conducting Search for New CEO Appoints James A. Soltesz as Chair and Louis P. “Pete” Mathews Jr. as Vice Chair of the Board of Directors, Effective Immediately BETHESDA, Md., Nov. 03, 2025 (GLOBE

Armada Hoffler Reports Third Quarter 2025 Results GlobeNewswire November 03, 2025 GAAP Net Loss of $0.04 Per Diluted Share for the Third Quarter Normalized FFO of $0.29 Per Diluted Share for the Third Quarter Positive Commercial Releasing Spreads of 6.0% (GAAP) and 6.6% (Cash) Approximately 270K Net Rentable Square Feet of New and Renewed Commercial

TELA Bio Appoints William Plovanic to Board of Directors GlobeNewswire November 03, 2025 MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (“Bill”)

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 03, 2025 LA JOLLA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on October 31, 2025, the Compensation Committee of Equillium's Board of Directors granted

Flux Power to Host Fiscal First Quarter 2026 Financial Results Conference Call on November 13, 2025 GlobeNewswire November 03, 2025 VISTA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, will report its fiscal

Hudson Technologies Announces CEO Departure and Succession Plan – Company Announces Strong Preliminary Third Quarter 2025 Results – GlobeNewswire November 03, 2025 WOODCLIFF LAKE, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) a leading provider of innovative and sustainable refrigerant products and services to the Heating, Ventilation, Air Conditioning, and Refrigeration

Glucotrack, Inc. Encourages Shareholders to Vote GlobeNewswire November 03, 2025 The Special Meeting of Shareholders reconvenes on November 7, 2025 Shareholders vote on Equity Purchase Agreement with Sixth Borough Capital Fund RUTHERFORD, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design,

Reed's Reports Third Quarter 2025 Results Management to Host Conference Call Tomorrow at 8:30 a.m. ET GlobeNewswire November 03, 2025 NORWALK, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) — Reed's, Inc. (OTCQX: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three and

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference GlobeNewswire November 03, 2025 Cambridge, Massachusetts, Nov. 03, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences,